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Abstract
Background: Recent observations point towards the existence of a large number of neighborhoods composed of
functionally-related gene modules that lie together in the genome. This local component in the distribution of the
functionality across chromosomes is probably affecting the own chromosomal architecture by limiting the
possibilities in which genes can be arranged and distributed across the genome. As a direct consequence of this
fact it is therefore presumable that diseases such as cancer, harboring DNA copy number alterations (CNAs), will
have a symptomatology strongly dependent on modules of functionally-related genes rather than on a unique
“important” gene.
Methods: We carried out a systematic analysis of more than 140,000 observations of CNAs in cancers and
searched by enrichments in gene functional modules associated to high frequencies of loss or gains.
Results: The analysis of CNAs in cancers clearly demonstrates the existence of a significant pattern of loss of gene
modules functionally related to cancer initiation and progression along with the amplification of modules of genes
related to unspecific defense against xenobiotics (probably chemotherapeutical agents). With the extension of this
analysis to an Array-CGH dataset (glioblastomas) from The Cancer Genome Atlas we demonstrate the validity of
this approach to investigate the functional impact of CNAs.
Conclusions: The presented results indicate promising clinical and therapeutic implications. Our findings also
directly point out to the necessity of adopting a function-centric, rather a gene-centric, view in the understanding
of phenotypes or diseases harboring CNAs.
Background
For many years, research into the genetic basis of many
different diseases has cumulated a large corpus of
knowledge on the links between particular genes and
diseases. However, most diseases are multigenic and
cannot be explained or characterized by a single gene
but rather by a combination of genes [1]. In a broad
sense, multigenecity reflects disruptions in proteins that
participate in a protein complex, in a pathway [2] or, in
general, in any known or yet to be discovered functional
unit or module.
It is widely accepted that most of the biological func-
tionality of the cell arises from complex interactions
between their molecular components that define func-
tional entities or modules that operate as small subcellu-
lar systems [3]. Recent evidence shows that genes
mapping in close physical locations in the chromosomes
tend to have a high degree of co-expression, that can
often be linked to common functionality [4]. We have
recently demonstrated that chromosomal regions
enriched in certain types of functions have arisen at
determinate evolutionary moments and have maintained
since then in the genomes along the evolution [5]. It is
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a well established fact that chromosomal regions change
their activity in diseases that harbor copy number altera-
tions, such as some cancers [6]. Moreover, examples of
disease-related genes mapping together in the genome
have recently been described [7,8].
Despite these observations, the strategy followed in
order to study pathologies harboring CNAs is still based
on finding one or a few target genes [9]. However, it
should be expected that modules composed of function-
ally-related genes, rather than one or a few key genes,
were affected by the chromosomal alterations.
The aim of this study is to evaluate the importance of
the functional component that can be attributed to the
co-localization of modules of functionally related genes
in those regions of the chromosomes that are lost or
gained during the curse of the disease, and the possible
impact that such component can have on its symptoma-
tology. An interesting model to test this hypothesis is
cancer. Genetic instability, producing not only point
mutations but mainly CNAs, has long been recognized
as a fundamental feature of many cancer types [10]. It
has been suggested that only a few essential functional
alterations in the physiology of the cells, the so-called
hallmarks of cancer, are behind the vast catalog of can-
cer genotypes [11]. Our hypothesis is that in most cases
such functions will be collectively carried out by mod-
ules of functionally-related genes that lay close together
in the chromosomes. Such modules could consequently
be found by analyzing the genomic regions most
affected by chromosomal instability.
To this end, a functional analysis of the genes located
in the regions undergoing copy number alterations in
different cancer types has been conducted. This analysis
aims to detect enrichments in cancer-related functions
significantly associated to chromosomal regions that are
systematically gained or lost in cancers. The conven-
tional way to determine the level of involvement of a
gene in the disease would imply the establishment of a
threshold beyond which the participation of the gene in
deletions of amplifications can be declared significant.
The way in which this threshold is fixed tends to be
arbitrary and can compromise the conclusions of the
work [12]. To avoid the imposition of artificial thresh-
olds, we have applied a generalization of the concept of
gene set analysis (GSA), previously proposed in the con-
text of transcriptomics [13] and further generalized to
other genomic domains such as evolution [14], QTL
analysis [15] and genotyping [16]. In the approach used
here a GSA test [14] is conducted to relate pre-defined
sets of functionally-related genes to a variable that
represents the propensity of a gene to be involved in a
deletion or in an amplification. Such variable is the
absolute frequency at which each gene is affected by
copy number alterations (CNAs) because it is located in
a lost or gained chromosomal region. This family of
methods based on the analysis of functionally-related
gene sets, (modules therein), are known to be more sen-
sitive than other alternative functional enrichment
methods [17-19].
Array-CGH constitute an ideal type of data, given that
they provide a detailed and accurate description of the
regions gained and lost and consequently a well defined
characterization of the genes included in them. Unfortu-
nately, there are still a limited number of such arrays
available in the databases. For example the progenetix
database [20], a repository of cytogenetic abnormalities
in cancer, contains only 3016 samples of array-CGH at
present (August 2009). The more general ArrayExpress
database contains 34 experiments, only 10 of which con-
tain the word cancer, summing up a total of only 463
samples. Both databases are highly overlapping and
include data from different platforms which makes the
analysis even more difficult [21]. With the exception of
initiatives such as The Cancer Genome Atlas [22], in
which large numbers of cancers are simultaneously ana-
lyzed with Array-CGH, most experiments involve small
numbers of samples. Small sample sizes of many experi-
ments hinder the possibility of obtaining significant
associations between gene modules and regions gained
or lost in cancers. However, this situation will eventually
change in the near future.
On the other hand, classical CGH assays provide an
alternative low-resolution description of regions gained
or lost. Fortunately, a large number of such observations
is available in repositories such as the Mitelman data-
base [23]. This is a manually curated repository that
relates chromosomal aberrations to tumour features,
based information extracted from the literature. Here
we conducted a systematic analysis of more than
140.000 observations of CNAs corresponding to losses
and gains of genetic material in cancers. The results
revealed a significant pattern of losses and gains of mod-
ules of functionally-related genes that will affect physio-
logical processes associated to cancer initiation and
progression. Consequently, a function-centric view,
which takes into account the cooperative effects of the
genes that integrate functional modules, can provide a




Classical cytogenetic techniques are more suitable for
detecting regional deletions (deletions affecting to
regions of the chromosomes, accounting for 19859 out
of a total of 86048 deletions reported in the Mitelman
database) than for detecting regional amplifications
(only 1011 out of a total of 55935) so, there is an
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unbalance between the number of observations in each
case, which constitutes an obvious limitation in the con-
clusions obtained for amplifications using this type of
data. Apparently this limitation did not seem to apply to
whole chromosome CNAs. There was a clear significant
negative correlation between the chromosome size and
the number of observed whole chromosome CNA dele-
tions. Probably this observation is reflecting the obvious
general fact that the smaller chromosomes have fewer
genes and their loss is potentially less damaging for the
cell. On the other hand, no equivalent trend could be
observed in the case of whole chromosome gains. In
this case an average of ~2000 observations (SD ~1000)
was recorded for all the chromosomes, except 7, 8 and
21, with 4156, 7013 and 4974 observations respectively.
These relevant exceptions were due to the specific and
highly recurrent presence of these chromosome aneu-
ploidies in well defined epithelial and hematological
cancers.
Particular behaviors of some chromosomes deserve to
be mentioned. For example, chromosome Y displayed a
large number of deletions but an abnormally low num-
ber of amplifications. An opposite trend was observed
for chromosomes 8 and 21. Particularly interesting is
chromosome 7 that showed an unexpectedly high num-
ber of amplifications and deletions simultaneously.
Although these observations have been extensively
reported, nothing is known about the advantageous bio-
logical reasons that a particular tumor may have due to
the acquisition of a chromosomal aberration along its
evolution.
Functional roles found in frequently lost regions
The analysis of 86048 deletion cases revealed a signifi-
cant loss of gene modules, defined by GO terms, that
can be related to the acquisition of most of the cancer
hallmarks [11]. The possible roles in cancer of the GO
terms found can be found by using text-mining tools,
such as the GOPubMed server [24]. Thus, mutability
could be increased in cancer cells by the loss of gene
modules with GO definitions such as “maintenance of
fidelity during DNA-dependent DNA replication” (p =
0.0299) and its direct descendant in the GO hierarchy
“mismatch repair” (p = 0.0942). “Cytoskeleton organiza-
tion and biogenesis” (p = 0.1488) has been linked to
genetic instability [25]. Metastatic state and tissue inva-
sion could be acquired by cancer cells when modules
such as “homophilic cell adhesion” (p = 3.8779 × 10-17),
and “calcium-dependent cell adhesion” (p = 2.0064 ×
10-08), both descendants of “cell adhesion” (see Figure 1)
are lost. Another module, whose loss is probably
involved in the metastatic state and tissue invasion too,
is “Localization of cell” (p = 0.0651), that refers to
processes by which a cell is transported to, and/or
maintained in, a specific location, related to the trans-
port and maintenance of proteins in the cell membrane.
The ontogenic relationships among GO terms depicted
in Figure 1 allows tracking “sulfate transport” (p =
0.0282) gene modules to processes related to “establish-
ment of localization”, a parent term of “establishment of
cellular localization” and putatively involve them in tis-
sue invasion and metastasis. Modules involved in
“homeostasis of number of cells” (p = 0.1265) are also
lost, probably contributing to the self-sufficiency in
growth signals and insensitivity to antigrowth signals,
two well known properties of cancer cells. The loss of
“interferon-alpha/beta receptor binding” (p = 0.0223)
function is probably mimicking the down-regulation of
b interferon (a factor which is known to elicit angiogen-
esis [26]) at cellular level. It is also known that extracel-
lular proteases are functionally linked to pro-angiogenic
integrins and both promote the invasive potential of
angiogenic endothelial cells [27]. The loss of “serine-
type endopeptidase inhibitor activity” (p = 0.0061) could
be behind the increase of such proteases. Table 1 and
Additional file 1 Tables S1, S2 and S3 contain modules
involved in other enzymatic functions related to cell
adhesion processes. Modules of genes located in cell
membranes and in intracellular junctions have been sig-
nificantly lost (Table 1) as well. Interestingly, gene mod-
ules of cytoskeleton filaments or microtubules were also
significantly lost. It is well known that the loss of genes
in these cellular structures leads to chromosomal
instability [25]. Since chromosomal instability generates
genetic heterogeneity, and it is fundamental to the pro-
cesses of neoplastic progression, it has recently been
proposed as another hallmark of cancer [28]. Some fea-
tures marked as “unrelated” in Table 1 are not directly
related to cancer and most probably account for specia-
lized characteristic of the differentiated cells that origi-
nated different cancer types. Some of these features
might have been discarded in the process of indifferen-
tiation process followed by many cancers.
All the functions described have been obtained by
analyzing all the cancers together. It is difficult to parti-
cularize the analysis in individual cancers given the poor
resolution of the technology and the comparatively
fewer cases recorded for individual cancers. Only in the
case of leukemia, with 6859 cases available, was it possi-
ble to find significant terms (see Additional file 1 Table
S4). Actually, a richer and more detailed picture of the
functions of the modules affected by the deletions is
obtained. Thus, in addition to processes related to cell
adhesion, localization of cell, sulfate transport and other
processes described above, more specific terms for sig-
naling were found, such as “cell-cell signaling” (p = 5.79
× 10-03) and some descendants or “cell surface receptor
linked signal transduction” (p = 5.18 × 10-03). Other
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interesting terms that can be associated to metastasis
would be “regulation of cell migration” (p = 0.0269).
Distinct modules related to phosporylation processes
have also been significantly lost. Finally, processes
related to the immune system, probably characteristic of
this type of cancer, were also lost, such as “antigen pro-
cessing and presentation” (p = 0.0159).
Additional File 2 contains the list of the genes for
each significant GO term with the corresponding chro-
mosomal locations and the number of CNAs in which
they are involved.
Functional roles found in frequently amplified regions
A similar analysis was performed with amplifications
although it turned out to be less conclusive because
there were far fewer cases corresponding to regional
amplifications (only 1011), probably because such ampli-
fications are more difficult to detect and properly char-
acterize with conventional cytogenetic analysis. Most of
the data used came from observations of whole-chromo-
some amplifications (54924 cases), so a higher impreci-
sion in the definition of the functional gene modules is
expected in this type of data. Table 2 shows biological
processes significantly associated to regions frequently
amplified in human cancers. The GO terms found refer
to very general processes, so the conclusions for the
amplifications are necessarily more speculative. Most of
the processes significantly amplified by cancer cells are
related to unspecific defense responses. All of them, but
especially “xenobiotic metabolic process” (p = 0.028646),
are most probably behind the response of the cancer
cells against the chemotherapy. Apart from the unspeci-
fic defense character of the processes “defense response
to fungus” (p = 0.018143) and “defense response to bac-
terium” (p = 1.759 × 10-11) both are significantly over-
represented in chromosome 8 (see next section), which
is one of the most frequently amplified. The biological
process “telomere maintenance” (with p = 0.14336, a
marginal significance if we consider a liberal threshold
of 0.15) is quite general but clearly accounts for the
immortalization of the cancer cells. Nevertheless we
cannot conclude whether the term “mismatch repair” (p
= 0.003339) has been amplified because it represents
gene modules related to any child term such as “nega-
tive regulation of mismatch repair” or because it is pre-
sent in chromosome 7 which exhibits a high number of
deletions and amplifications simultaneously. In any case,
if chromosome 7 is examined for functional enrichment
[29] the term “mismatch repair” is significantly over-
represented in it.
Chromosome-specific functional roles
While many of the observations made for functional
roles lost are based on regional deletions, the observa-
tions made for functional roles gained are almost exclu-
sively based on whole chromosome gains. This fact
Figure 1 GO terms significantly associated to chromosomal regions frequently lost in cancers. Since a large number of GO terms are
tested, the popular FDR method [34] was used to adjust the p-values for multiple-testing effects obtained when conducting a one-tailed test
[14]. GO terms with p-values under a conventional threshold of p < 0.05 were represented as red octagons and GO terms under a more liberal
0.05 < p < 0.15 were represented as blue octagons. White squares represent non-significant terms connecting the significant terms found. The
picture has been obtained using the GoGraphViewer utility of the Babelomics package http://www.babelomics.org[44].
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suggests the existence of a strong regionalization of the
functional units composed by gene modules. While the
concentration of functionally-related genes in neighbor-
hoods has already been described [4], the existence of
chromosome-specific functions, beyond the obvious
ascribed to the sexual chromosomes, has not systemati-
cally been explored. Additional file 1 Table S5 shows
the results obtained upon the application of a functional
enrichment method [29] that finds significant over-
representations of functional terms in each chromo-
some. Surprisingly only a few chromosomes -12, 13, 14,
15 and 21- are not significantly enriched in any func-
tionally-related gene module. Some of the chromosome-
specific gene modules present in frequently amplified
Table 1 GO terms most significantly associated to chromosomal regions frequently lost in cancers.










homophilic cell adhesión GO:0007156 114 3.8779 × 10-
17
4.77 × 10-18 Metastasis and
invasion
calcium-dependent cell-cell adhesion GO:0016339 22 2.0064 × 10-
08
9.88 × 10-9 Metastasis and
invasion
synaptogenesis GO:0007416 30 1.2491 × 10-
05
1.46 × 10-6 Unrelated
sensory perception of taste GO:0050909 18 0.00510791 0.00299 Unrelated
cellular component organization and biogenesis GO:0016043 2165 0.01731139 0.0764 Replicative potential
fertilization (sensu Metazoa) GO:0009566 54 0.02135039 0.0648 Unrelated
sulfate transport GO:0008272 12 0.02815271 0.00961 Metastasis and
invasion
maintenance of fidelity during DNA-dependent DNA
replication
GO:0045005 28 0.02990008 0.0141 Mutability
male gamete generation GO:0048232 210 0.0449652 0.210 Unrelated
localization of cell GO:0051674 410 0.06513653 0.697 Metastasis and
invasion
mismatch repair GO:0006298 27 0.09421995 0.0113 Mutability
cell cycle GO:0007049 805 0.09599886 1.00 Replicative potential
Molecular function
pancreatic ribonuclease activity GO:0004522 15 0.0046537 0.000623 Metastasis and
invasion?
serine-type endopeptidase inhibitor activity GO:0004867 89 0.0060532 0.000767 Angiogenesis
nucleotide binding GO:0000166 1993 0.0064466 0.00183 Mutability?
sulfate porter activity GO:0008271 10 0.0078682 0.00279 Metastasis and
invasion
interferon-alpha/beta receptor binding GO:0005132 10 0.022324 0.0180 Angiogenesis
carboxypeptidase A activity GO:0004182 25 0.032232 0.0156 Metastasis and
invasion?
lipoxygenase activity GO:0016165 7 0.040851 0.0696 Metastasis and
invasion?
Cellular component
cytoskeletal part GO:0044430 613 0.0000647 0.0000153 Chromosomal
instability
microtubule organizing center part GO:0044450 26 0.014677 0.00849 Chromosomal
instability
intermediate filament cytoskeleton GO:0045111 153 0.014677 0.00924 Chromosomal
instability
integral to plasma membrane GO:0005887 1180 0.042474 1.50 × 10-001 Metastasis and
invasion
Given that many GO terms are tested, the popular FDR and Bonferroni methods were used to adjust for multiple-testing effects the p-values obtained when
conducting a one-tailed test (see details in [14]). GO terms with p-values under a conventional threshold of p < 0.05 are listed. GO terms under a more liberal 0.05 <
p < 0.15 are listed in Additional file 1 Tables S1, S2 and S3. Rightmost column makes reference to the cancer feature most probably related to the GO term.
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chromosomes correspond, obviously, to functions sys-
tematically gained in cancers (e.g. defense response to
bacterium or defense response to fungus in chromo-
some 8 or mismatch repair in chromosome 7). Although
the existence of biological functions specific of one or of
a few chromosomes does not seem to be a frequent
occurrence (we must remember that there are several
thousands of GO terms), some of these, however, are
clearly over-represented in some chromosomes. This
observation suggests that when a complete chromosome
is lost or gained (a frequent event in cancer) the activity
of whole modules of genes carrying out a particular bio-
logical role are dramatically changed.
Fine-scale analysis of CNAs of functional roles lost in
glioblastoma
After proving the sensitivity of the method proposed for
analyzing the functional impact of CNAs in a large data-
set with low resolution we essayed a smaller dataset
with higher resolution. We downloaded 294 Array-CGH
experiments of glioblastomas [30] from The Cancer
Genome Atlas [22]. The data was already segmented in
the repository and the CNA coordinates were available
and well defined. Despite the fact that the number of
samples is comparatively smaller than in the case of
CGH (in the range of one order of magnitude lower)
the resolution of the Array-CGH was good enough to
obtain significant results. Table 3 lists the functional
modules present in regions significantly lost. The losses
of several processes are relevant in the particular con-
text of this cancer. For instance, the highly significant
“neurological process” (p = 4.45 × 10-12) and their des-
cendants (see Figure 2) are probably related to the
undifferentiation process o neuronal cells. Also other
processes related to chromosomal instability are related,
such as “chromatin assembly” (p = 1.60 × 10-05) and a
number of parent terms have been lost. Several descen-
dants of “signal transduction”, probably related to self-
sufficiency in growth signals, have also been significantly
lost. Interestingly, “oxygen transport” (p = 0.0263), was
also found to be significantly lost. Our group recently
proved the link between undifferentiation and hypoxia
[31]. It is tempting to speculate that the loss of genes
related to oxygen transport can be used by the cancer to
gain or to mimic some sort of state of undifferentiation.
The results demonstrate the importance of having
high-resolution Array-CGH data. With only 294 samples
we have found well defined and highly significant terms.
In the conventional CGH case we needed almost two
orders of magnitude more samples to obtain similar
results.
Discussion
Given the poor resolution that classical cytogenetic
techniques have, the analysis presented here can be con-
sidered as a coarse-grain view of the real importance of
neighborhoods of modules composed by functionally-
related genes. The extension of this methodology to the
analysis of the data produced by Array-CGH [32] has
demonstrated to be straightforward. Also the results are
noticeably better when a reasonable number of samples
are analyzed. The forthcoming deluge of data foresee-
able from such high-throughput platforms will allow
refining the results presented here in a near future.
Moreover, more sophisticated methods of error correc-
tion in the GSA methods will result in more specific
and accurate findings in the future [33]. In this study we
have used the popular FDR, that keeps false discoveries
at a reasonable rate without being too conservative [34].
Despite its low resolution and limitations, the analysis
based on cytogenetic data resulted to be sensitive
enough to reveal the existence of an important number
of gene modules, significantly associated to regions sys-
tematically deleted in cancers, whose functionalities (as
represented by GO terms) clearly account for cancer-
related biological processes and molecular roles. Simi-
larly, regions systematically amplified by cancer cells are
significantly populated by genes carrying out processes
related to cell immortalization and to unspecific defense
(probably against chemotherapeutical agents). When the
vast catalog of cancer cell genotypes is analyzed in
detail, a small number of functional alterations, also
Table 2 GO terms corresponding to the “biological process” ontology significantly associated to chromosomal regions
frequently amplified in cancers.




defense response to bacterium GO:0042742 98 1.7594 × 10-11 2.98 × 10-11
mismatch repair GO:0006298 27 0.003339 0.0020
xenobiotic metabolic process GO:0006805 29 0.028646 0.169
defense response to fungus GO:0050832 13 0.018143 0.101
telomere maintenance GO:0000723 24 0.14336 0.303
GO terms with p-values under a conventional threshold of p < 0.05 are listed in boldface. Also, GO terms under a more liberal p < 0.15 are listed in normal face.
Nominal p-values obtained by conducting the one-tailed test (see details in [14]) were adjusted for multiple testing using the FDR [34] and the more
conservative Bonferroni corrections.
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denominated hallmarks of cancer by some authors
[11,28], seems to account for all this complexity. These
altered functions shared by most (if not all) cancers are:
self-sufficiency in growth signals, insensitivity to anti-
growth signals, evasion of apoptosis, limitless replicative
potential, sustained angiogenesis, and tissue invasion
and metastasis [11]. Interestingly, losses and gains of
gene modules carrying out functions (whose GO terms
are compatible with the acquisition of all of them) were
found. Moreover, another well-established feature of
cancer, the acquisition of multi drug resistance by
amplification of chromosomal regions [35] was also
found to depend on the amplification of the correspond-
ing gene modules (amplification of the “xenobiotic
metabolic process” GO term; see table 2). Finally, the
enabling characteristic for the acquisition of these func-
tionalities, genomic instability, also considered a cancel
hallmark by other authors [28], has been clearly
detected by our analysis. The analysis of leukemia in the
CGH data and the analysis of the TCGA glioblastomas
data [30] revealed, in addition to processes related to
general cancer properties, other affected processes
related to particular characteristics of the cancer types.
The emerging picture from this study is a scenario in
which cancer cell populations undergo a Darwinian
dynamics along the distinct phases of the disease [36],
which mainly occurs by genetic modifications caused by
chromosomal instability [10,28]. This chromosomal
instability, affecting large chromosomal regions, is the
substrate of a strong selective pressure operating on a
reduced number of cellular functions leading to cancer
[37]. Our hypothesis, consistent with the results found,
is that in a considerable number of cases such functions
will be carried out by modules of genes that are located
in neighborhoods along the chromosomes rather than
by one or few key genes.
Regardless of the fact that some recent evidences link
chromosomal physical location to function [4,5] and
that disease-related genes have been recently described
as mapping in adjacent positions in the chromosomes
[6-8], the putative impact that this local distribution of
cellular functionality could have in the symptomatology
of diseases that harbor CNAs still remains largely
unexplored.
Conclusions
The systematic study presented here has firmly related,
for the first time, molecular functional roles of gene
modules involved in CNAs to biological processes
related to cancer initiation and progression. Our conclu-
sions point to the necessity of taking a more function-
centric perspective to understand the functional effect of
CNAs, especially in the context of cancer. Even more
important is the relevance of these findings for the
design of therapeutic strategies in the treatment of can-
cer. Also, drug discovery processes need to account for
Table 3 GO terms corresponding to the “biological process” ontology significantly associated to chromosomal regions
frequently lost in the glioblastomas [30].




sensory perception of chemical stimulus GO:0007606 9.83 × 10-24 1.97 × 10-17
sensory perception GO:0007600 2.39 × 10-17 7.17 × 10-14
neurological process GO:0050877 4.45 × 10-12 1.78 × 10-06
G-protein coupled receptor protein signaling pathway GO:0007186 5.44 × 10-8 0.0272
chromatin assembly GO:0031497 1.60 × 10-5 0.000799
chromatin assembly or disassembly GO:0006333 1.85 × 10-5 0.00011
cell surface receptor linked signal transduction GO:0007166 0.00028 0.00169
DNA packaging GO:0006323 0.00204 0.01740
establishment and/or maintenance of chromatin architecture GO:0006325 0.00204 0.02042
protein-DNA complex assembly GO:0065004 0.00204 0.01926
chromosome organization and biogenesis (sensu Eukaryota) GO:0007001 0.00217 0.02389
chromosome organization and biogenesis GO:0051276 0.00234 0.02819
lipid metabolic process GO:0006629 0.02525 0.17675
gas transport GO:0015669 0.02628 0.15771
oxygen transport GO:0015671 0.02628 0.15771
organelle organization and biogenesis GO:0006996 0.03449 0.41390
regulation of liquid surface tension GO:0050828 0.04568 0.04568
The one-tailed test, as implemented in the GSA version provided by the Babelomics package [44], was used (see details in [14]). Nominal p-values were adjusted
for multiple testing using the FDR [34] and the Bonferroni methods.
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this new scenario [38,39]. The recent observation of an
unexpectedly widespread distribution and prevalence of
CNA polymorphisms in the human genome [32] makes
even more urgent the adoption of a viewpoint in which
gene modules, instead of genes in isolation, are consid-
ered to be behind most phenotypes or disease symp-
toms. Our findings are consistent with the idea that
pathways, rather than individual genes, appear to govern
the course of tumorigenesis [40,41].
Methods
Database of chromosomal alterations
The Mitelman database of Chromosome Aberrations in
Cancer http://cgap.nci.nih.gov/Chromosomes/Mitelman
was used as primary source of information. A total of
86048 observations (independent CNA event described in
the database) of deletions (19859 of them corresponding
to regional deletions affecting only to parts of the chro-
mosomes and 66189 to whole chromosome deletions),
including any type of cancer, were obtained from the
database. Each individual case in the database has a
description of the associated CNA in a standard format
with the indication of the cytoband or cytobands affected
by the deletion or the amplification; for example del(7)
(p13p15). Although with a smaller coverage, amplifica-
tions were also stored in the database. A total of 55935
observations of amplifications corresponding to 1011
regional amplifications and 54924 whole chromosome
amplifications were retrieved from the database.
In order to avoid possible artifacts of erroneous obser-
vations, we have only taken into account deletions or
amplifications occurring at least in two cases.
Figure 2 GO terms significantly associated to chromosomal regions frequently lost in glioblastomas [30]. Since a large number of
GO terms are tested, the popular FDR method [34] was used to adjust the p-values for multiple-testing effects obtained when conducting a one-
tailed test [14]. GO terms with p < 0.05 were represented as octagons. White squares represent non-significant terms connecting the significant
terms found. The picture has been obtained using the GoGraphViewer utility of the Babelomics package http://www.babelomics.org[44].
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Array-CGH data from TCGA
The Cancer Genome Atlas [22] was used as the source
for Array-CGH data on cancer. A large experiment with
294 Array-CGH (Agilent 244 K) of glioblastoma was
used [30]. The data already segmented was available and
was retrieved for the analysis.
Gene mapping
Genes were mapped to their corresponding cytobands
using the Ensembl database [42], release 45, Homo
sapiens (NCBI 36).
Functional annotations and representation
The widely accepted GO functional categories [43] were
used for the functional profiling of the genes involved in
CNAs. The GO annotations for the human genes were
provided by the ID-converter engine of the Babelomics
package [44]http://www.babelomics.org which contains
annotations taken from the GO database [43]. GO
terms corresponding to levels 3 to 6 in the hierarchy
were tested. This correspond to a total of 3549 Biologi-
cal Process, 2817 Molecular Function and 394 Cellular
Component GO terms
Figure 3 Schematic representation of the gene-set enrichment procedure followed. (a) The CNAs are mapped onto the chromosomal
coordinates and then used to (b) build up a ranked list of cytobands, which is further used to (c) define a ranking of genes according to how
frequently are they involved in CNAs. The distribution of gene modules, in this case the annotations of a fictitious GO, derived from such ranked
list is tested for its significant accumulation in frequently lost regions. (d) The variant of the GSA test used [14] seeks for significant asymmetrical
distributions of annotations (red bars) with respect to the annotation background (blue bars). The × axis in d represents the number of cases in
which a gene has been observed in region affected by a CAN (that, generally speaking can be either amplification or a loss). The bar height
represents the number of genes involved in a given frequency of CNA events. The red bars represent the distribution of the genes of a given
GO across the frequency of observations of CNAs. The GSA test seeks for GOs whose distributions are significantly skewed towards high or low
frequencies of CNAs. Since a large number of GO terms are tested, the FDR method [34] was used to adjust the p-values for multiple-testing
effects. The Mitelman database of Chromosome Aberrations in Cancer http://cgap.nci.nih.gov/Chromosomes/Mitelman, May 2007 release, was
used as primary source of information. A total of 86048 observations of deletions (corresponding 19859 to regional deletions and 66189 to
whole chromosome deletions), and 55935 observations of amplifications (corresponding to 1011 regional amplifications and 54924 whole
chromosome amplifications) including any type of cancer, were obtained from the database.
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Plots of the relationships existent among GO terms
can be obtained by using the GO visualization tools
implemented in the Babelomics package [44].
Chromosomal functional enrichment
The significance in the enrichment of functional terms
in chromosomes was carried out with the FatiGO [29]
program as implemented in the Babelomics package
[44]http://www.babelomics.org. Briefly, the program
builds a 2 × 2 contingency table for each functional
term checked and applies an exact Fisher ’s test.
The resulting p-values are adjusted to compensate
multiple-testing effects using the popular FDR method
[34].
Functional profiling of genes more frequently involved in
CNAs
Since the annotation, given the resolution of the cytoge-
netic technique, was made at the level of cytobands,
these were chosen as operational units for this study.
Different deletions in different cases spanned over dis-
tinct chromosomal regions (Figure 3a). Then, the num-
ber of times that a cytoband was deleted or was part of
a larger deletion was counted up. Next, the cytobands
were ranked according to the frequency of its occur-
rence in the observations reported in the database (Fig-
ure 3b). These frequency values were used to build up a
list of genes ranked according to the number of times
the cytoband in which they were located was lost in the
observations (Figure 3c). Once this list is completed, the
association of modules of functionally-related genes
(defined here using GO terms) to high values of the
rank (that is: high frequency of deletion; see Figure 3d)
is tested. Exactly the same process can be followed with
amplifications.
We used for this purpose a gene-set functional profiling
method. This methodology, introduced in the field of
microarray data analysis [13], comprises a family of meth-
ods that allows studying the coordinate over- or under-
representation of pre-defined gene sets in the extremes of
a list of genes ranked by some criteria [45]. In particular
we have used a generalized GSA test [14] implemented
in the Babelomics package [44]. This algorithm has the
advantage of dealing directly with the ranked list, without
requiring either any extra information or the original
experimental values [14]. In particular, the test seeks for
significant asymmetrical distributions of GO terms across
consecutive partitions of the ranked list [14]. If the term
is systematically over-represented in the upper part of the
partitions (corresponding to the genes more frequently
deleted) we will consider that this GO functionality is
systematically deleted. The same rationale can be applied
to the list ranked by frequency of amplifications. The
FDR method [34] was used to adjust the p-values for
multiple-testing effects given that a large number of GO
terms are tested.
GO definitions [43], obtained as explained above, were
used to define such gene modules composed of func-
tionally-related genes.
Validation of the roles of biological processes in cancer
The GoPubmed [24], a tool that relate terms to genes
using sophisticated textmining methods was used to
check whether the biological processes found were linked
to cancer by co-citations in the scientific literature.
Additional material
Additional file 1: File containing supplementary tables. Contains the
following additional tables: Additional Table S1. GO terms corresponding
to the “biological process” ontology significantly associated to
chromosomal regions frequently lost in cancers. The one-tailed test, as
implemented in the GSA version provided by the Babelomics package
was used. Nominal p-values were adjusted for multiple testing using the
FDR. Liberal p-values < 0.15 are listed in the table. P-values < 0.05 are
represented in boldface. GO terms are arranged by p-values. See Figure 1
for a representation of the relationships among he GO terms. Additional
Table S2. GO terms corresponding to the “molecular function” ontology
significantly associated to chromosomal regions frequently lost in
cancers. The one-tailed test, as implemented in the GSA version provided
by the Babelomics package was used. Nominal p-values were adjusted
for multiple testing using the FDR. Liberal p-values < 0.15 are listed in
the table. P-values < 0.05 are represented in boldface. GO terms are
arranged by p-values. Additional Table S3. GO terms corresponding to
the “cellular component” ontology significantly associated to
chromosomal regions frequently lost in cancers. The one-tailed test, as
implemented in the GSA version provided by the Babelomics package
was used. Nominal p-values were adjusted for multiple testing using the
FDR. Liberal p-values < 0.15 are listed in the table. P-values < 0.05 are
represented in boldface. GO terms are arranged by p-values. Additional
Table S4. GO terms corresponding to the “biological process” ontology
significantly associated to chromosomal regions frequently lost in
leukemia. The one-tailed test, as implemented in the GSA version
provided by the Babelomics package was used. Nominal p-values were
adjusted for multiple testing using the FDR. Liberal p-values < 0.15 are
listed in the table. P-values < 0.05 are represented in boldface. GO terms
are arranged by p-values. Additional Table S5. GO terms corresponding
to the “biological process” ontology significantly over-represented in the
chromosomes found by the functional enrichment test implemented in
the FatiGO program. The one-tailed test, as implemented in the program
was used to check for significance. Nominal p-values were adjusted for
multiple testing using the FDR. GO terms are arranged by p-values.
Additional file 2: ZIP file containing tab-delimited text files for GO
terms. One text file for each significant GO term. Each file contains one
line per gene belonging to the GO. Each line lists the Ensembl ID, the
Gene Name, the number of cases in which the gene was involved in a
CNA, and its location including: Chromosome, Band, Start (bp) and End
(bp).
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